EU-South Africa partnership: Green energy and beyond DW 03/14/2025EU pledges $5 billion to South Africa for green energy and vaccine manufacturing, reaffirming commitment post-US funding withdrawal.
EU to invest $5bn in South Africa after US aid withdrawal DW 03/13/2025EU announces $5 billion investment for South Africa focusing on clean energy and vaccine manufacturing amid US aid cuts.
EU-South Africa partnership: Green energy and beyond DW 03/14/2025EU pledges $5 billion to South Africa for green energy and vaccine manufacturing, reaffirming commitment post-US funding withdrawal.
EU to invest $5bn in South Africa after US aid withdrawal DW 03/13/2025EU announces $5 billion investment for South Africa focusing on clean energy and vaccine manufacturing amid US aid cuts.
AstraZeneca ditches 450m investment in UK plantAstraZeneca abandoned plans for a £450 million investment in Merseyside due to decreased government support.
AstraZeneca's 450 million vaccine plant at risk as government reconsiders financial backingThe Treasury is in talks with AstraZeneca regarding a £450 million vaccine facility, but funding support is significantly reduced, raising concerns about investment viability.
Fresh blow for Rachel Reeves as AstraZeneca scraps 450m investment in vaccine plantAstraZeneca cancels a £450 million investment in UK due to insufficient government support, indicating challenges in the life sciences sector.
AstraZeneca ditches 450m investment in UK plantAstraZeneca abandoned plans for a £450 million investment in Merseyside due to decreased government support.
AstraZeneca's 450 million vaccine plant at risk as government reconsiders financial backingThe Treasury is in talks with AstraZeneca regarding a £450 million vaccine facility, but funding support is significantly reduced, raising concerns about investment viability.
Fresh blow for Rachel Reeves as AstraZeneca scraps 450m investment in vaccine plantAstraZeneca cancels a £450 million investment in UK due to insufficient government support, indicating challenges in the life sciences sector.
Britain must build own vaccine manufacturing capability, says Matt HancockBritain needs to establish its own vaccine manufacturing capability to ensure timely access during future pandemics.